September 11th 2024
EASD 2024: New data shows survodutide may be beneficial for persons with obesity and MASH.
September 10th 2024
Your daily dose of the clinical news you may have missed.
September 6th 2024
Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.
August 27th 2024
The Omnipod 5 is now the first automated insulin delivery system available for both T1D and T2D in the US.
August 16th 2024
Primary care clinicians can screen at-risk individuals for type 1 diabetes with a single autoantibody panel. It pays to test and educate early, according to this author.
ADA 2018: New Basal Insulins go Head-to-Head
How do 2nd generation basal insulin formulations perform vs their predecessors? We report highlights of 3 important studies from the ADA 78th Scientific Sessions.
Obesity Briefs from the AACE Annual Scientific & Clinical Congress
Highlights include: POC A1c testing in prediabetes screening, first-year weight loss after bariatric surgery, and predicting fracture risk in obese patients.
Tiny Diabetes Tech in the Pipeline
A tooth-mounted sensor, a glucose monitor built into a smartphone case, plus 3 more new “gee whiz” devices that could transform diabetes care.
Holy Hypoglycemia!
Hypoglycemic episodes are uncomfortable, disruptive, and dangerous; 3 ways to help T2DM patients avoid and also correct them.
Rx Shorts: Long-acting Insulin Confusion
New long-acting insulin products are winning preferred formulary status, pushing old standards aside. Here, pointers on the new options.
Rx Shorts: ED Drugs Go Generic in 2018
Treatment for erectile dysfunction may finally be affordable, available, and convenient.
My T2DM Patient is Not at Goal with Metformin . . . What’s Next?
A 52-year-old woman with T2DM is on metformin, works with a dietitian, and exercises regularly, but her hemoglobin A1c has increased. What would you advise?
9 New Drugs for Primary Care: Q1 2018
The "new year" is now in full swing and new drugs are being approved each month; check out our slideshow to get up to date on 9 drugs approved in the first quarter for primary care.
Aldosterone’s Resurgence in Hypertension: a Primary Care Primer
Since aldosterone has become a pivotal hypertensive hormone, screening with or without confirmation should be part of primary care practice. Here's a straightforward approach.
T2 Diabetes: Target Albuminuria and Blood Pressure
Attention to a few easily obtained details can prevent serious sequelae in patients with T2 diabetes complicated by cardiovascular and renal disease.
Reconsider Beta-Blockers for Patients with Diabetes?
This study demonstrated that in patients with type 2 diabetes mellitus, use of β-blockers was associated with an increased risk for cardiovascular events and severe hypoglycemia. Details here.
11 New Medications for Primary Care
Here: a quick look at newly approved agents for primary care that will soon be coming your way.
Artificial Sweeteners and their Contradictory Outcomes
A new meta-analysis finds that routine intake of artificial sweeteners is linked to weight gain and metabolic dysfunction. Wait, what?
5 More Top Endo Apps for Primary Care
Apps to guide osteoporosis treatment, insulin management, endocrine emergencies, plus ADA and Endo Society standards of care, at-a-glance.
Atrial Fibrillation and Type I Diabetes: What's the Link?
A first-of-its-kind study reports an association between T1DM and AF, and between glycemic control and AF. Plus, there are gender differences.
5 Top CKD Apps for Primary Care Physicians
Chronic renal disease is common in primary care settings and so are its comorbidities. In brief here, 5 apps you might want at hand.
Medicare Ups Provider Incentive for Prediabetes Intervention
Providers may now be paid up to $785 (increased from $450) for each patient who loses 5% of their body weight.
Adding Pounds in Adulthood Ups Major Health Risks
Study: each gain of 5 kg was linked to a 17% drop in odds of healthy aging. A powerful message for young patients.
Asthma Diagnosis Associated with Type 1 Diabetes
Results from studies on the asthma-diabetes connection are inconsistent. A novel analysis may help clarify directionality.
Hyperbilirubinemia and Diffuse Skin Lesions in a Woman with Diabetes, CVD
Can you identify the cause of the hyperpigmented umbilicated lesions seen bilaterally on the patient's extremities and on her back?
Treatment Strategies to Limit Hypoglycemia
Studies summarized in this slide show focus on fine-tuning insulin-containing regimens to enhance glucose control and avoid variability.
Climate Change Health Hazards Quiz
Test your knowledge of the products of climate change and the health effects they may have.
ADA 2017: Hypoglycemia and the Role of Glycemic Variability
Glycemic variability fuels hypoglycemia but in one study from ADA 2017 is found to actually help predict hypoglycemic events.
ADA 2017: Evaluating Cardiovascular Safety of Antidiabetic Agents
Cardiovascular risk/benefit profiles of pioglitazone and the SGLT2 inhibitor class are summarized, based on reports at ADA 2017.
ADA 2017: CV Complications of Diabetes
A1C vs FPG to diagnose prediabetes; prediabetes and CHF; and how much weight loss is too much? Reports from ADA 2017.
ADA 2017: Insulins go Head-to-Head
Insulin degludec vs glargine--which costs less per anum and why? We summarize this study and 2 other direct insulin comparisons reported at ADA 2017.
ADA 2017: Oral Agents Under Review
When to start screening for B12 deficiency in your diabetes patients taking metformin? We review a dose-response diet study plus 2 others on oral drugs.
Climate Change Is a Health Hazard: 8 Examples
Increases in diabetes, insomnia, and skin cancer are just 3 of the hazardous trends identified in recent research. More findings in our slide show.
Postmarket Drug Safety Quiz: 8 Questions About Risk
Test your knowledge of the safety events that have occurred involving FDA-approved drugs since the turn of the century.
Post-Test on T2DM Back-to-Basics Special Report
Try these 10 questions and see what you've learned during this month's special report on the nuts-and-bolts of T2DM for PCPs.